Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
Warfarin vs. Asprin in Reduced Ejection Fraction
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
No. at risk<br />
Ma<strong>in</strong> Secondary Outcome<br />
<strong>Warfar<strong>in</strong></strong> 3,519 patient years 447 endpo<strong>in</strong>ts<br />
Aspir<strong>in</strong> 3,582 patient years 435 endpo<strong>in</strong>ts<br />
<strong>Warfar<strong>in</strong></strong><br />
(12.70% per year)<br />
Aspir<strong>in</strong><br />
(12.15% per year)<br />
Overall HR 1.07 = (093,1.23) p=0.33<br />
Aspir<strong>in</strong> 1163 1004 750 554 419 270 75<br />
<strong>Warfar<strong>in</strong></strong> 1142 954 735 541 426 291 88
Change language